Clinically studied, drug-free postbiotic now available nationally SHELTON, Conn., Aug. 14, 2025 /PRNewswire/ -- Parents across the U.S. now have…
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the…
Built to Connect Patients and Providers, the HFSA Database is Now Open for Searching and Submissions WASHINGTON, Aug. 14, 2025…
NEW CASTLE, Del., Aug. 14, 2025 /PRNewswire/ -- IgniteData, a leader in intelligent clinical trial data automation, today announced the close…
- Live video webcast on Tuesday, August 19th at 2:40 PM ET HOUSTON, TX / ACCESS Newswire / August 14,…
Calgary, Alberta--(Newsfile Corp. - August 14, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous stem cell…
Patient visits are now complete in the final cohort of Phase 1b trial, consisting of Parkinson’s disease patients receiving 300…
The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately…
Live video webcast on Wednesday, August 20th at 2:40 PM ETOCALA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech…
Following constructive FDA feedback on its proposed statistical analysis plan, Clene plans to analyze the neurofilament light data from its…